NEW YORK – With no signs that the coronavirus pandemic is anywhere close to abating, many have pointed to the need for an easy-to-use, quick, and inexpensive test that could identify those with SARS-COV-2 relatively accurately.
Last week, Abbott Laboratories appeared to answer that call when its BinaxNow COVID-19 Ag Card antigen test received Emergency Use Authorization from the US Food and Drug Administration, making it the sixth test for the coronavirus in Abbott's portfolio.